Skip to main content

Peer Review reports

From: A Pfs48/45-based vaccine to block Plasmodium falciparum transmission: phase 1, open-label, clinical trial

Original Submission
9 Nov 2023 Submitted Original manuscript
5 Jan 2024 Reviewed Reviewer Report - Martina Oneko
11 Jan 2024 Reviewed Reviewer Report - Titus Kwambai
12 Feb 2024 Reviewed Reviewer Report - Philip Bejon
19 Feb 2024 Reviewed Reviewer Report
12 Mar 2024 Author responded Author comments - Manon Alkema
Resubmission - Version 2
12 Mar 2024 Submitted Manuscript version 2
13 Mar 2024 Reviewed Reviewer Report - Philip Bejon
15 Mar 2024 Reviewed Reviewer Report - Titus Kwambai
15 Mar 2024 Reviewed Reviewer Report
19 Mar 2024 Reviewed Reviewer Report - Martina Oneko
2 Apr 2024 Author responded Author comments - Manon Alkema
Resubmission - Version 3
2 Apr 2024 Submitted Manuscript version 3
Publishing
2 Apr 2024 Editorially accepted
23 Apr 2024 Article published 10.1186/s12916-024-03379-y

You can find further information about peer review here.

Back to article page